Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucienne Costa-Frossard

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Frontiers in Neurology|April 8, 2020
The Broad Concept of "Spasticity-Plus Syndrome" in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis SymptomsÓscar Fernández, Lucienne Costa-Frossard, Marisa Martínez-Ginés, et al.
Enfermeria Clinica|August 6, 2016
[Management of symptoms associated with spasticity in patients with multiple sclerosis]María Asunción Fernández-Pablos, Lucienne Costa-Frossard, Carlos García-Hernández, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 21, 2012
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosisLuisa M Villar, Mercedes Espiño, Lucienne Costa-Frossard, et al.
Frontiers in Neurology|October 14, 2021
Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat<sup>®</sup> MethodologyOscar Fernandez, Lucienne Costa-Frossard, Maria Luisa Martínez-Ginés, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2011
Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromesLuisa M Villar, Mercedes Espiño, Ernesto Roldán, et al.
American Journal of Ophthalmology|February 13, 2013
Color-code agreement among stratus, cirrus, and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis with and without prior optic neuritisGema Rebolleda, Julio J González-López, Francisco J Muñoz-Negrete, et al.
Cureus|December 20, 2024
A Clinical Care Algorithm for Detecting Progression in Multiple Sclerosis: RetratEMos ProjectJosé E Meca-Lallana, René Robles, Lamberto Landete, et al.
Multiple Sclerosis and Related Disorders|June 19, 2022
The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosisAndrés Labiano-Fontcuberta, Lucienne Costa-Frossard, Susana Sainz de la Maza, et al.
Journal of the Neurological Sciences|January 3, 2016
Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosisJosé C Álvarez-Cermeño, Francisco J Muñoz-Negrete, Lucienne Costa-Frossard, et al.
Biomed Research International|October 15, 2014
Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosisJulio J González-López, Gema Rebolleda, Marina Leal, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Neurology|April 8, 2020
The Broad Concept of "Spasticity-Plus Syndrome" in Multiple Sclerosis: A Possible New Concept in the Management of Multiple Sclerosis SymptomsÓscar Fernández, Lucienne Costa-Frossard, Marisa Martínez-Ginés, et al.
Enfermeria Clinica|August 6, 2016
[Management of symptoms associated with spasticity in patients with multiple sclerosis]María Asunción Fernández-Pablos, Lucienne Costa-Frossard, Carlos García-Hernández, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 21, 2012
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosisLuisa M Villar, Mercedes Espiño, Lucienne Costa-Frossard, et al.
Frontiers in Neurology|October 14, 2021
Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat<sup>®</sup> MethodologyOscar Fernandez, Lucienne Costa-Frossard, Maria Luisa Martínez-Ginés, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2011
Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromesLuisa M Villar, Mercedes Espiño, Ernesto Roldán, et al.
American Journal of Ophthalmology|February 13, 2013
Color-code agreement among stratus, cirrus, and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis with and without prior optic neuritisGema Rebolleda, Julio J González-López, Francisco J Muñoz-Negrete, et al.
Cureus|December 20, 2024
A Clinical Care Algorithm for Detecting Progression in Multiple Sclerosis: RetratEMos ProjectJosé E Meca-Lallana, René Robles, Lamberto Landete, et al.
Multiple Sclerosis and Related Disorders|June 19, 2022
The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosisAndrés Labiano-Fontcuberta, Lucienne Costa-Frossard, Susana Sainz de la Maza, et al.
Journal of the Neurological Sciences|January 3, 2016
Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosisJosé C Álvarez-Cermeño, Francisco J Muñoz-Negrete, Lucienne Costa-Frossard, et al.
Biomed Research International|October 15, 2014
Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosisJulio J González-López, Gema Rebolleda, Marina Leal, et al.
Pageof 10